Skip to main content

Resources

Resources

Featured

White PaperJune 2026

AI in Biomedicine: From Discovering Drugs to Predicting Biology

How functional cellular data unlocks a new generation of diagnostics, clinical decision support, and personalized medicine

Gal Lenz, PhD, CSO — TeraCyte

As AI transforms healthcare, the greatest opportunity is not discovering more drugs, but predicting which therapies will work, for which patients, and when. This white paper introduces the concept of Predictive Biology and describes how functional cellular data can unlock a new generation of diagnostics, clinical decision support, and personalized medicine.

Read White Paper

Press & Media

News & Media

Haaretz
Press

The Future of Personalized Medicine: Live Cells on a Silicon Chip

Haaretz covers TeraCyte's silicon imaging platform and its potential to transform personalized medicine by reading immune cell behavior in real time.

Read Article
TheMarker
Press

TeraCyte: Predicting the Immune System's Next Move

TheMarker profiles TeraCyte's approach to immune intelligence and the commercial opportunity in predictive cytometry for clinical applications.

Read Article
Globes
Press

Call for Proposals to Join TeraCyte's Initiative

Globes report on the Israel Innovation Authority initiative and TeraCyte's call for proposals to build the data layer powering AI-driven biological prediction.

Read Article
Technion BCF
Ecosystem

New at BCF: TeraCyte Joins the BioConvergence Facility

The Technion BioConvergence Facility welcomes TeraCyte as a resident company, marking a key milestone in their deep-tech development and academic collaboration.

Read Article
Israel Innovation Authority
Grant

IBFI AI Model Sciences Program

TeraCyte was selected by the Israel Innovation Authority for the IBFI AI Model Sciences program, supporting the development of AI models for biological applications.

Read Article
MedTech Innovator
Recognition

BioTools Innovator Announces Top 19 Life Sciences Companies Named to the 2023 Cohort

TeraCyte was selected among the top 19 life sciences companies named to the BioTools Innovator 2023 cohort, recognizing its impact in life science tools and diagnostics.

Read Article
YouTube
Video

TeraCyte Video Interview

Watch TeraCyte founders discuss the science behind Temporal Cytometry™, the vision for Predictive Biology, and the path to clinical deployment.

Watch Interview

Conferences & Recognition

Events & Recognition

Kenes Exhibitions
Conference

BioMed Israel 2025

Speaker: Gal Lenz

Gal Lenz presented TeraCyte's Predictive Biology platform at BioMed Israel 2025 — Israel's largest life science and biotech conference.

Learn More
Tel Aviv University
Conference

AI & Health Day — AI Week 2025

Speakers: Gal Lenz & Maya Finkler

Gal Lenz and Maya Finkler presented at AI & Health Day during AI Week 2025, exploring how temporal immune data enables clinical AI at scale.

Learn More
BioTools Innovator
Recognition

BioTools Innovator Portfolio

TeraCyte is featured in the BioTools Innovator portfolio — a curated network of high-impact life science tool companies shaping the future of biology.

Learn More
ARC
Recognition

ARC Portfolio

TeraCyte has been recognized as part of the ARC portfolio. Full details coming soon.

Link coming soon

Get in Touch

Interested in a partnership or collaboration?

We work with pharmaceutical companies, biotech organizations, research institutions, and investors.

Contact TeraCyte